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Figure S1: Structure and Maldi TOF spectra of dinuclear zinc complexes with phosphorylated amino acids and phosphorylated peptides. A. Mass spectrum and structure of Zn 2 (EtL 1 ) . 2H 2 BO 3 . CH 3 CN (calculated mass 881.15; observed mass = 881.9) B. Mass spectrum and structure of Zn 2 (EtL 1 ) -phosphoserine (calculated mass =901.5; observed mass = 898.9). C. Mass spectrum and structure of Zn 2 EtL 1 complexed to 13 amino acid long C terminal phosphorylated Akt peptide, phospho-Akt2-13mer (calculated mass =2364.1; observed mass =2361.9). This 13-mer contains the hydrophobic motif of the C-terminus, as well as pSer474, and so is the targeted epitope. D. Mass spectrum and structure of Zn 2 L 1 -Az4-PEG 2 -Biotin (calculated mass M.2H 2 O = 1370.2, (M-N 2 ) .2H 2 O = 1342.2; observed mass M.2H 2 O = 1369, (M-N 2 ) .2H 2 O = 1343.8) (PEG = polyethylene glycol). E. Mass spectrum and structure of Zn 2 L 1 -Az4-PEG 2 -Biotinphosphoserine (calculated mass = 1457.22; observed mass =1454.4). F. Mass spectrum and structure of Zn 2 L 1 -Az4-PEG 2 -Biotin -phosphotyrosine (calculated mass = 1532.31; observed mass = 1532.39). G. Mass spectrum and structure of Zn 2 L 1 -Az4-PEG 2 -Biotin complexed to the peptide substrate for the pSrc protein Ac-I-pY-GEF (calculated mass = 2019.86; observed mass =2019.57). o ligand is linked to the Zn chelator using the Cu(I) catalyzed click reaction. The synthesized molecule 2 binds to the Akt2 fragment containing pS474 to form Complex-2, which is used as the target in the biligand screen. C. Molecular structure of the biligand bi-L isolated in the screen against the target peptide. 1 o ligand (in red) is linked, through Cu catalyzed Alkyne Azide Cycloaddition (CuAAC) reaction, to the 2 o ligand (in blue). D. An azide is appended at the N terminal of the 2 o peptide to synthesize peptide anchor-3N, which is used in screening for 3 o ligands that click to the N-terminus of the biligand. E. An alkyne is appended to the C terminal of the 1 o peptide to synthesize peptide anchor-3C, which is used in screening for 3 o ligands that click to the C-terminus of the biligand. 
1.8e5 0.0046 2.5e-8 Figure S7 : Sensograms from Surface Plasmon Resonance (SPR) experiment, immobilizing N-tL on SA chip and using Akt2 protein as the analyte. A. The data were fit to a simple 1:1 binding model using global analysis in Biacore T100 Evaluation software. The equilibrium dissociation constant K D is 25 nM, which is in close agreement with the ELISA EC 50 value of 19 nM. The in vitro phosphorylation of GSK3α/β substrate by active Akt2 is inhibited when treated with increasing concentrations of the C-tL ligand. The solutions are ran on a gel and visualized by treatment with pGSK3α/β Ser 21/9 antibody. The western blot image was scanned and the signal corresponding to different concentrations of C-tL was quantitated using ImageJ. The density was normalized to the signal for no inhibitor (DMSO control) to generate an activity percentage value curve in GraphPad Prism 6.0. An EC 50 value of 4 µM is obtained from the curve using non-linear regression. Table S2 : Hit sequences from biligand (bi-L) screen with 25 nM target peptide. Consensus motifs are highlighted. Table S3 : Hit sequences from biligand screen with 10 nM target peptide. Consensus motifs are highlighted. under reflux for 3 days and then allowed to cool to room temperature [1] . Then dichloromethane (300 mL) and water (100 mL) was added to the reaction mixture and a liquid phase extraction was done. The organic phase, containing the compound, was washed once with 300 mL of water and dried over anhydrous sodium Zn 2 L 1 -Az4-PEG 2 -Biotin solution were also subjected to the Maldi TOF. In the mixed solutions, the peaks corresponding to the adduct of the dinuclear Zinc complex to the phosphoamino acid or phosphopeptides were observed ( Figure S1 ).
Solid phase peptide synthesis:
General protocol: Peptides were synthesized on Rink Amide MBHA, Biotin Novatag, Biotin PEG Novatag and Sieber Amide resin either manually or on the Titan 357 Automatic Peptide Synthesizer (AAPPTec, Louisville, KY). Amino acid solutions in NMP (2 equivalents), with 2 equivalents of HATU and 6 equivalents of DIEA were used for the amino acid coupling reaction. For removal of Nα-Fmoc protecting groups, a solution of 20% piperidine in DMF was used.
Acylation:
The resin was treated with a solution of anhydrous acetic anhydride and 2,6-lutidine (Sigma) in DMF (acetic anhydride: 2,6-lutidine: DMF; 5:6:100), twice for ten minutes at room temperature. The excess reagents were removed by five washes with DMF.
Cleavage of side chain protected peptides:
The peptides were synthesized on Sieber Amide resin. The resin was treated three times for one minute with 1% TFA/DCM and then washed with DCM. The peptide solution was neutralized by adding 2 equivalent DIEA and rotavaped. The semisolid was dissolved in filtered DMSO, HPLC grade acetonitrile and double distilled water and purified on the HPLC.
Cleavage of side chain deprotected peptide:
The peptides were synthesized on the Rink Amide MBHA, Biotin Novatag or Biotin PEG Novatag resin. The resin was treated with a TFA cleavage solution (TFA:
TES: ddH 2 O; 95:2.5:2.5) for two hours at room temperature. The cleavage solution was filtered through a Gooch filter crucible and added dropwise to an ice cooled solution of diethyl ether.
HPLC purification of peptides: All the peptides were purified using a gradient of double distilled water and HPLC grade acetonitrile and 0.1% TFA on the RP-HPLC (Beckman Coulter System Gold 126 Solvent
Module and 168 Detector) using a C18 reversed phase semi-preparative column (Phenomenex Luna 10 µm, 250 × 10 mm).
Protocol for on bead copper (Cu) catalyzed azide alkyne cycloaddition (CuAAC) click reaction: On bead
Cu catalyzed click reactions were performed with the azide on bead and the alkyne in solution. The resin was treated with 2 equivalents of the relevant alkyne, 1.5 equivalents of CuI (Sigma) and 2.5 equivalents of ascorbic acid (Sigma), in a solution of 20% piperidine in DMF. The reaction was performed overnight at room temperature. The excess copper was removed from the resin by washing extensively with a Cu chelating solution (5% (w/v) sodium diethyl dithiocarbamate, 5% (v/v) DIEA in DMF).
Peptide library Synthesis:
Randomized OBOC [2] libraries of hexapeptides were synthesized using the Titan 357 Automated
Peptide Synthesizer (AAPPTec) on 90 µm polyethylene glycol-grafted polystyrene beads (TentaGel S-NH2, 0.28 mmol/g, 2.86 x 1020
propargylglycine. In library C, for azide incorporation, Fmoc-L-azido lysine (Anaspec) was coupled to the N termini of the on bead peptides. All the libraries contained 10% D-Methionine at the C terminal, for compatibility with Maldi-TOF/ TOF sequencing. The 10% Methionine was incorporated following literature protocol [3] . 
Synthesis and characterization of peptide ligands and intermediates

Synthesis and characterization of mono-L:
Fmoc-NH-PEG 2 -OH was coupled using standard Fmoc protocol on Biotin Novatag resin. 1.5 equivalents of D, L-Fmoc-azidolysine were coupled on the resin followed by acylation. On bead Cu catalyzed click reaction was carried out following described protocol using 2 equivalents of Fmoc-D-Pra-O t Bu. After washes with the copper chelating solution the peptide was acylated. The resultant molecule S1 (figure S10) was cleaved off the resin using TFA cleavage solution.
The crude solid was used in further synthesis.
The peptide wkvkl was made on Rink Amide MBHA resin (Anaspec) following standard Fmoc SPPS synthesis protocol. 1.5 equivalents of S1 were then coupled to the peptide. After TFA cleavage the ligand mono-L was purified using a gradient of water and acetonitrile and 0.1% TFA on the RP-HPLC. Following removal of the Fmoc protecting group, the amine terminal was acylated. After TFA cleavage the resultant molecule S4 (figure S13) was lyophilized and the crude solid was used in further synthesis. The peptide wkvkl was made on Rink Amide MBHA resin. 1.5 equivalents of S4 were then coupled to the peptide. On bead click reaction was carried out with two equivalents of Fmoc-D-Pra-O t Bu. After washes with copper removing solution, the peptide was further extended to hngyf on the N terminal using standard Fmoc SPPS synthesis. Fmoc-L-azidolysine was then coupled, followed by acylation of the amine terminal.
After TFA cleavage Anchor-3N was purified using a gradient of water and acetonitrile and 0.1% TFA on Fmoc-D-lysine(Alloc)-OH was deprotected using standard alloc deprotection technique [4] . Then 4-pentynoic acid was coupled. After TFA cleavage, Anchor-3C was purified using a gradient of water and acetonitrile and 0.1% TFA on the RP-HPLC. 
Synthesis and characterization of N-tL:
Side chain protected version of Ac-D-Pra-yyrfG-CONH 2 was made on Amide Sieber resin. The protected peptide was cleaved off using 1% TFA in DCM and purified using a gradient of water and acetonitrile and 0.1% TFA on the RP-HPLC. Anchor-3N was made on resin as described and then acylated using standard acylation method. On bead click reaction was carried out for the bead bound Anchor-3N with 2 equivalents of side chain protected purified peptide Ac-yyrfG-CONH 2 .
The resin was washed with copper chelating solution. The peptide was cleaved off the resin with the TFA cleavage solution and purified using a gradient of water and acetonitrile and 0.1% TFA on the RP-HPLC. with guanidium hydrochloride and water, and sequenced using the Edman Peptide Sequencer.
Screen for bi-L:
Prescreen: 2 batches of 135 mg of library B (XXXXX-D-Pra-10% M-TG, Supplementary table S1) were washed in water, and swelled overnight in binding buffer (25 mM Tris-Cl (pH = 7.7), 150 mM NaCl, Table S5 , along with the probability that the sequence is a binder to the protein and not a background binder (clear beads). The probability arises from the poor resolution of certain amino acid standards in the Edman sequencer during sequencing the hits from the N terminal triligand target screen.
Selection of final N terminal triligand N-tL:
Two sequences were observed (table S5) which were not background binders (remain clear in the antibody binder elimination screen) and which had the full probability of being the right sequence. These two 3° peptides, D-Pra-yyrfG and D-Pra-ssGry, were clicked to anchor-3N by CuAAC reaction and tested as triligand candidates (N-tri1 and N-tri2 respectively).
These were used to immunoprecipitate Akt2 from OVCAR3 cells ( figure S5 ). The first triligand candidate N-tri1 being more efficient was chosen as the final N terminal triligand N-tL.
Screen for C-tL:
Prescreen: 500 mgs of library C (H 2 N-Az4-XXXXX-10%M-TG, table S1) was swelled in binding buffer overnight. The beads were incubated with 100 µM solution of anchor-3C in binding buffer for two hours at 4°C. The protocol for the prescreen for N-tL screen was followed. The blue hit beads, which were background binders to the anchor-3C or the detection antibody were separated from the rest of the beads.
The clear beads were stringently washed with DMF, guanidium hydrochloride and water and used in the product screen that followed.
Product screen: The washed beads from the prescreen were swelled overnight in binding buffer 100 uM solution of anchor-3C was incubated for thirty minutes at 4°C with 50 nM Akt2 in binding buffer. The solution was added to the beads and shaken at 4°C for two hours. The protocol for the N-tL product screen was followed. The blue hit beads were picked up manually, stringently washed with DMF, guanidium hydrochloride and water, and sequenced on the Edman Sequencer. The sequences are recorded in Table S6 .
Selection of the final C terminal triligand C-tL: Four triligand candidates were synthesized with L-Az4-hdGGf (C-t1), L-Az4-hdGsf (C-t2), L-Az4-hdGww (C-t3), L-Az4-hdGkf (C-t4) as the 3° peptide arm.
Binding of the candidates to the target peptide epitope was determined in an ELISA assay ( Figure S6 ) and the ligand C-t1 emerged as the best binder. C-t1 was chosen as the C terminal triligand C-tL.
Epitope/ Protein Selectivity Assay: The selectivity assay with full length His 6 tagged Akt1, Akt2 and Akt3 was performed following the same protocol, using 25 nM protein instead of 2.5 µM His 6 tagged peptide epitope.
Measurement of binding affinity of N-tL by Surface Plasmon Resonance:
A Biacore T100 m a c h i n e was used for SPR experiments. A Streptavidin Chip (Series S, G.E.
Healthcare) was conditioned as per manufacturer's recommendation. A s t o c k o f 1 m M biotinylated ligand was diluted into HBSP+ Buffer (G.E. Healthcare) to a final concentration of 100 nM
